Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

A Mechanism Randomised Controlled Trial of a Three-Agent LLM-Augmented mHealth Intervention for Late-Life Loneliness in Older Adults

10 settembre 2026 aggiornato da: The University of Hong Kong
This study examines how a smartphone conversational application affects feelings of loneliness in Cantonese-speaking older adults living in Hong Kong. Seventy-two adults aged 60 or above who report at least moderate loneliness will be randomly assigned to one of two versions of the same application. Both versions look and work the same way, offer the same three conversational companions, and provide the same set of in-app tools. The two versions differ only in how the companions' replies are produced: in one version replies are generated by a large language model, and in the other they are assembled from pre-written templates selected by keyword and conversation state. Participants use the application for four weeks and are then followed for a further four weeks with continued access. The main question is whether any difference between the two versions in emotional loneliness operates through how understood, validated and cared for participants feel during individual conversations. Participants are not told which version they are using, and the researcher who carries out the assessments is also unaware of the assignment.

Panoramica dello studio

Descrizione dettagliata

Loneliness in later life is associated with adverse physical and mental health outcomes. Conversational applications based on large language models have been proposed as a scalable form of support, but most published evaluations remain at the pilot feasibility stage, and few have used a comparator that holds interface richness, attention, and novelty constant. Without such a comparator, any observed benefit cannot be attributed to the language model rather than to the surrounding experience.

This trial addresses that gap using an architecturally matched comparator. Both arms deliver the identical mobile application: the same visual interface, navigation, three named conversational companions, tool layer, and in-app assessment prompts. The sole difference is the backend that generates companion response content. In the Hybrid arm, responses are generated by a large language model using each companion's system prompt, conversation history, and user input, and the arm exhibits language-model-distinctive conversational behaviours including anchoring on specific content, cross-session memory, explicit admission of unfamiliarity, mixed-content routing, and generative summarisation. In the Rule-based arm, responses are produced by a template system driven by keyword matching and conversational state, without cross-session memory and without those behaviours; conversational content in this arm is not transmitted to any external service.

Seventy-two community-dwelling Cantonese-speaking adults aged 60 or above who score at least 2 on the De Jong Gierveld Emotional and Social Loneliness Scale are allocated 1:1, stratified by baseline emotional loneliness using permuted blocks within stratum, with allocation concealment. A designated staff member performs randomisation and onboarding and does not collect outcome data. The Principal Investigator conducts all in-person assessments while unaware of allocation. Participants are not informed which version they use and are debriefed at study completion.

The intervention period is four weeks, followed by four weeks of follow-up with continued application access and continuous usage logging. The primary analysis is a longitudinal 1-1-1 multilevel mediation model with arm as the between-person predictor, session-level perceived responsiveness as the within-person mediator, and emotional loneliness as the outcome; the indirect effect is tested using Monte Carlo confidence intervals. The study is powered for the indirect effect rather than for confirmatory testing of the between-arm main effect, which is reported as an effect estimate with a 95% confidence interval. A falsifiable specification of the proposed mechanism is that an arm advantage appears on emotional loneliness but not on social loneliness.

A three-layer safety architecture operates in both arms: a Cantonese-calibrated distress detector that surfaces Hong Kong crisis resources in real time and alerts the research team; a daily 100% audit of Thought Exercise events against pre-specified scope criteria; and weekly Principal Investigator review of all flags and audits. Pre-specified pause criteria are an intervention-related serious adverse event, boundary-crossed events exceeding 10%, or distress detector recall below 0.90 on a real Cantonese corpus.

Tipo di studio

Interventistico

Iscrizione (Stimato)

72

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

Sì

Descrizione

Inclusion Criteria:

  • Aged 60 years or above
  • Self-identified Cantonese as primary language of communication
  • Community-dwelling in Hong Kong (not in residential care)
  • De Jong Gierveld Emotional and Social Loneliness Scale total score of 2 or above at screening, indicating at least moderate loneliness
  • Owns a smartphone, or willing to use a study-provided device
  • Able to demonstrate understanding of the study using the teach-back method
  • Willing to provide written informed consent

Exclusion Criteria:

  • Acute suicidality, defined as a PHQ-9 item 9 score above 1 with reported active intent
  • Currently receiving formal psychiatric treatment
  • Severe hearing or visual impairment precluding application use even with accommodation
  • Self-reported diagnosis of dementia or significant cognitive impairment
  • Unable to demonstrate understanding of the study using the teach-back method
  • Prior participation in the feasibility phase of this research programme

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Scienza basilare
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Doppio

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Hybrid arm (LLM-driven)
Participants receive the mobile application with companion responses generated by a large language model backend, using each companion's system prompt, conversation history, and user input. Language-model-distinctive conversational behaviours (content anchoring, cross-session memory, admission of unfamiliarity, mixed-content routing, generative summarisation) are operationally present. Recommended use is at least three sessions per week over four weeks; actual use is at the participant's discretion and is logged.
Mobile application providing three named Cantonese-language conversational companions plus four in-app tools (Action Loop, Thought Exercise, Education, Progress). Companion replies are generated turn-by-turn by a large language model (DeepSeek-V3, accessed via Firebase Cloud Functions), conditioned on the companion's system prompt, retrieved conversation history, and current user input. This arm can therefore produce five conversational behaviours the comparator cannot: anchoring on specific content the participant has just said, memory carried across separate sessions, explicit admission of unfamiliarity, routing of single messages containing mixed emotional and informational content, and generative summarisation. Occurrences are tagged in system logs and analysed as a cumulative within-arm exposure variable. Conversational text is transmitted to the model provider for response generation; participants are advised at consent not to include identifying information. Recommended use is a
Comparatore attivo: Rule-based arm (template-driven)
Participants receive an application identical in interface, navigation, companion personae, tool layer, and in-app assessment prompts, with companion responses produced by a template system driven by keyword matching and conversational state. Cross-session memory and the language-model-distinctive behaviours are absent. Conversational content is not transmitted externally. Recommended use and logging are identical to the Hybrid arm.
Mobile application identical to the experimental arm in interface, navigation, companion names and personae, tool layer (Action Loop, Thought Exercise, Education, Progress), notification schedule, and all in-app assessment prompts. The sole difference is the response-generation backend: companion replies are assembled from pre-written templates selected by keyword matching and conversational state, with no language model involved. The system retains no memory across sessions, cannot anchor on unanticipated content, cannot admit unfamiliarity outside scripted cases, and cannot generate novel summaries. Conversational content is not transmitted to any external service. This is an attention- and interface-matched active comparator rather than a waitlist or usual-care control: participants receive equivalent contact time, interface richness, tool access, and prompting schedule. Recommended use, expected daily duration, and logging are identical to the experimental arm.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Session-level perceived responsiveness (primary mediator)
Lasso di tempo: After each conversation session, Weeks 1 through 4
Brief perceived-responsiveness measure administered in-app immediately after each companion conversation. Single-item sliders scored 1-7 covering Understanding, Validation, Caring and Insensitivity. Higher scores indicate greater perceived responsiveness. This is the within-person mediator in the pre-specified primary mediation model, not an efficacy endpoint.
After each conversation session, Weeks 1 through 4
Change in emotional loneliness (De Jong Gierveld emotional subscale)
Lasso di tempo: Baseline (Week 0) and Week 4
De Jong Gierveld Emotional and Social Loneliness Scale, 3-item emotional subscale. Score range 0-3; higher scores indicate greater emotional loneliness. Change from baseline to Week 4. This is the outcome variable in the pre-specified primary mediation model. The trial is powered for the indirect effect via session-level perceived responsiveness and is not powered for confirmatory testing of the between-arm difference, which is reported as an effect estimate with a 95% confidence interval.
Baseline (Week 0) and Week 4

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

21 settembre 2026

Completamento primario (Stimato)

31 dicembre 2026

Completamento dello studio (Stimato)

31 dicembre 2026

Date di iscrizione allo studio

Primo inviato

10 settembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

10 settembre 2026

Primo Inserito (Effettivo)

16 settembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

16 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

10 settembre 2026

Ultimo verificato

1 settembre 2026

Maggiori informazioni

Termini relativi a questo studio

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi